[go: up one dir, main page]

ATE392152T1 - Coenzym q10 formulierungen - Google Patents

Coenzym q10 formulierungen

Info

Publication number
ATE392152T1
ATE392152T1 AT03702603T AT03702603T ATE392152T1 AT E392152 T1 ATE392152 T1 AT E392152T1 AT 03702603 T AT03702603 T AT 03702603T AT 03702603 T AT03702603 T AT 03702603T AT E392152 T1 ATE392152 T1 AT E392152T1
Authority
AT
Austria
Prior art keywords
coenzyme
formulations
matrix
droplets
gelatin
Prior art date
Application number
AT03702603T
Other languages
English (en)
Inventor
Chyi-Chen Chen
Bruno Leuenberger
Johann Ulm
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE392152T1 publication Critical patent/ATE392152T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Soft Magnetic Materials (AREA)
AT03702603T 2002-02-14 2003-02-06 Coenzym q10 formulierungen ATE392152T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02003433 2002-02-14

Publications (1)

Publication Number Publication Date
ATE392152T1 true ATE392152T1 (de) 2008-05-15

Family

ID=27675622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03702603T ATE392152T1 (de) 2002-02-14 2003-02-06 Coenzym q10 formulierungen

Country Status (9)

Country Link
US (1) US20050142123A1 (de)
EP (1) EP1476032B1 (de)
JP (1) JP2005517031A (de)
CN (1) CN1633245A (de)
AT (1) ATE392152T1 (de)
AU (1) AU2003205738A1 (de)
DE (1) DE60320380T2 (de)
ES (1) ES2302913T3 (de)
WO (1) WO2003068008A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2371362B1 (de) 2004-01-22 2020-07-01 University of Miami Coenzym-Q10-Formulierungen zur Behandlung von soliden Tumoren durch intravenöse Gabe
WO2006123173A1 (en) * 2005-05-19 2006-11-23 Kilda Biolink As Gelatin-containing topical composition
JP5134535B2 (ja) * 2005-06-29 2013-01-30 ディーエスエム アイピー アセッツ ビー．ブイ． イソフラボンナノ粒子およびその使用
EP1909763A2 (de) * 2005-07-28 2008-04-16 Isp Investments Inc. Benzochinone mit erhöhter bioverfügbarkeit
JP2009502969A (ja) * 2005-07-28 2009-01-29 アイエスピー インヴェストメンツ インコーポレイテッド 非晶質エファビレンツ及びその製造
WO2007014566A2 (en) * 2005-08-04 2007-02-08 Basf Aktiengesellschaft Microcapsules and their use
JP2007161656A (ja) * 2005-12-15 2007-06-28 Arimino Kagaku Kk 毛髪化粧料
US20070184040A1 (en) * 2006-02-06 2007-08-09 Clouatre Dallas L Compositions for delivery of coenzyme Q10
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
US8613946B2 (en) 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
WO2008092057A2 (en) 2007-01-26 2008-07-31 Isp Investments Inc. Formulation process method to produce spray dried products
MX352434B (es) 2007-03-22 2017-11-24 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
US20100092560A1 (en) * 2007-04-16 2010-04-15 Kaneka Corporation Reduced coenzyme q10-containing particulate composition and method for producing the same
CN101288641B (zh) * 2007-04-19 2012-07-11 浙江一新制药股份有限公司 辅酶q10水分散体及其制备方法
KR20100047869A (ko) * 2007-07-19 2010-05-10 디에스엠 아이피 어셋츠 비.브이. 친유성 헬스 성분의 정제화가능한 배합물
US20110136231A1 (en) 2008-04-11 2011-06-09 Cytotech Labs, Llc Methods and use of inducing apoptosis in cancer cells
KR101016741B1 (ko) 2008-07-16 2011-02-25 재단법인서울대학교산학협력재단 유비데카레논-함유 고체분산체의 제조방법
JP5903735B2 (ja) 2009-05-11 2016-04-13 バーグ エルエルシー エピメタボリックシフター（コエンザイムｑ１０）を使用した疾患の処置方法
EA032941B1 (ru) 2010-03-12 2019-08-30 БЕРГ ЭлЭлСи ЛЕКАРСТВЕННЫЕ ФОРМЫ КОЭНЗИМА Q10 (CoQ10) ДЛЯ ВНУТРИВЕННОГО ВВЕДЕНИЯ И ИХ ПРИМЕНЕНИЕ
CN102258474B (zh) * 2010-05-24 2012-10-10 富阳科兴生物化工有限公司 自微乳型辅酶q10粉状干乳的制备方法
CN102258473B (zh) * 2010-05-24 2013-03-13 富阳科兴生物化工有限公司 自微乳型辅酶q10粉状干乳及其应用
EP2694463B8 (de) 2011-04-04 2019-10-09 Berg LLC Behandlung von tumoren im zentralnervensystem mit coenzym q10
US10973763B2 (en) 2011-06-17 2021-04-13 Berg Llc Inhalable pharmaceutical compositions
JP6065585B2 (ja) * 2012-12-28 2017-01-25 ユーハ味覚糖株式会社 ガレート型カテキン含有化粧料
CN105338973A (zh) 2013-04-08 2016-02-17 博格有限责任公司 使用辅酶q10联合疗法治疗癌症
ES2825083T3 (es) 2013-09-04 2021-05-14 Berg Llc Métodos de tratamiento contra el cáncer mediante infusión continua de coenzima Q10
JP6287123B2 (ja) * 2013-11-29 2018-03-07 ユーハ味覚糖株式会社 ユビキノール含有液状組成物
CN114711336A (zh) * 2014-08-25 2022-07-08 安纳塔拉生命科学有限公司 避免抗微生物剂抗性的抗腹泻制剂
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN110200910B (zh) * 2019-06-17 2022-04-19 北京中超海奇科技有限公司 一种辅酶q10透明水分散液的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951214A (ja) * 1982-09-16 1984-03-24 Taiho Yakuhin Kogyo Kk バイオアベイラビリテイの高い薬剤の製造方法
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
US5284674A (en) * 1992-05-11 1994-02-08 Fazio Susan C Powdered dairy creamer
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
EP0966889B1 (de) * 1998-06-24 2007-05-02 DSM IP Assets B.V. Vitaminpulver zur verwendung für getränke
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020103139A1 (en) * 2000-12-01 2002-08-01 M. Weisspapir Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control

Also Published As

Publication number Publication date
DE60320380T2 (de) 2009-05-20
JP2005517031A (ja) 2005-06-09
EP1476032A1 (de) 2004-11-17
WO2003068008A1 (en) 2003-08-21
US20050142123A1 (en) 2005-06-30
DE60320380D1 (de) 2008-05-29
EP1476032B1 (de) 2008-04-16
AU2003205738A1 (en) 2003-09-04
CN1633245A (zh) 2005-06-29
ES2302913T3 (es) 2008-08-01

Similar Documents

Publication Publication Date Title
DE60320380D1 (de) Coenzym q10 formulierungen
BRPI0411001A (pt) produtos aril-heteroaromáticos, composições que os contêm e utilização
UY28348A1 (es) Compuestos novedosos
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
TW200734364A (en) Curable composition containing thiol compound
BRPI0616071B8 (pt) métodos de revestir uma micropartícula cristalina pré-formada em suspensão com um agente ativo
EA200701246A1 (ru) Стабильные при комнатной температуре составы дронабинола
SV2007002422A (es) Derivados del (1,5-difenil-1h-pirazol-3-il)oxadiazol, su preparacion y su aplicacion en terapeutica.
ITRM20010464A1 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
CY1112591T1 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
ATE399467T1 (de) Komprimierte harz-moderierte kaugummi
DE50204688D1 (de) N-alkylaziridinoprepolymere als dentalmasse
ATE452646T1 (de) Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat
EA200601759A1 (ru) Композиции рамиприла
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
BR0313751A (pt) Heterociclilpirimidinas substituìdas
DE60315711D1 (de) Aliphatische polyesterharz-zusammensetzung
EA200300917A1 (ru) Порошковый состав
EA200400343A1 (ru) Композиция с контролируемым высвобождением кларитромицина или тинидазола
DE602004004085D1 (de) Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel
ATE419882T1 (de) Finishing-pulver
HRP20090239T1 (en) 4-hydroxy tamoxifen gel formulations
BRPI0501052A (pt) composição cosmética à base de papaìna

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties